![Mark Winderlich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Winderlich
Corporate Officer/Principal at
HOOA PHARPAR
Profile
Mark Winderlich is currently the Chief Development Officer at HOOKIPA Pharma, Inc. He previously worked at Evotec SE as the EVP & Global Head-Scientific Operations.
Dr. Winderlich holds a graduate degree from Heidelberg University (Ohio) and a doctorate degree from Max-Planck-Institute for Molecular Genetics.
Mark Winderlich active positions
| Companies | Position | Start |
|---|---|---|
| HOOA PHARPAR | Corporate Officer/Principal | 01/04/2024 |
Former positions of Mark Winderlich
| Companies | Position | End |
|---|---|---|
| EVOTEC SE | Corporate Officer/Principal | - |
Training of Mark Winderlich
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
12
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
Heidelberg University (Ohio)
 Heidelberg University (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Max-Planck-Institute for Molecular Genetics
 Max-Planck-Institute for Molecular Genetics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HOOKIPA Pharma, Inc.
 HOOKIPA Pharma, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company which develops pharmaceutical products for immunotherapeutics targeting infectious diseases and cancers | Health Technology |
- Stock Market
- Insiders
- Mark Winderlich
